References
- Ashe, P. C. and M. O. Berry. 2003. Apoptotic signaling cascades. Prog. Neuropsychopharmacol. Biol. Psychiatry 27: 199-214
-
Atkinson, E. A., H. Ostergaard, K. Kane, M. J. Pinkoski, A. Caputo, M. W. Olszowy, and R. C. Bleackley. 1996. A physical interaction between the cell death protein Fas and the tyrosine kinase
$p59^{fyn}$ . J. Biol. Chem. 271: 5968-5971 https://doi.org/10.1074/jbc.271.11.5968 - Bae, M. A., H. S. Kang, S. W. Rue, J. H. Seu, and Y. H. Kim. 1998. Enhanced expression of Fas ligand is associated with aburatubolactam C-induced apoptosis in human Jurkat T cells. Biochem. Biophys. Res. Commun. 246: 276-281 https://doi.org/10.1006/bbrc.1998.8598
- Bae, M. A., K. Yamada, Y. !juin, T. Tsuji, and K. Yazawa. 1996. Aburatubolactam A, a novel inhibitor of superoxide anion generation from a marine microorganism. Heterocyclic Commun. 2: 315-318
- Bae, M. A., K. Yamada, O. Uemura, J. H. Seu, and Y. H. Kim. 1998. Aburatubolatam C, a novel apoptosis-inducing substance produced by marine Streptomyces sp. SCRC A-20. J. Microbiol. Biotech. 8: 455-460
- Cascino, I., G. Papoff., R. De Maria, R. Testi, and G. Ruberti. 1996. Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protect tumor cells from Fas-mediated apoptosis. J. Immunol. 156: 13-17
- Chang, S. H., C. O. Oh, M. S. Yang, S. S. Kang, Y. S. Lee, J. K. Sonn, and J. S. Chun. 1998. Protein kinase C regulates chondrogenesis of mesenchymes via mitogen-activated protein kinase signaling. J. Biol. Chem. 273: 19213 -19219 https://doi.org/10.1074/jbc.273.30.19213
- Datta, R., Y. Manome, N. Taneja, L. H. Boise, R. Weichselbaum, C. B. Thompson, C. A. Slapak, and D. Kufe. 1995. Overexpression of Bel- XL by cytotoxic drug exposure confers resistance to ionizing radiation-induced interriucleosomal DNA fragmentation. Cell Growth Differ. 6: 363-370
- Eichhorst, S. T., M. Muller, M. Li-Weber, H. SchulzeBergkamen, P. Angel, and P. H. Krammer. 2000. A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs. Mol. Cell. Biol. 20: 7826-7837 https://doi.org/10.1128/MCB.20.20.7826-7837.2000
- Eischen, C. M., B. L. Williams, W. Zhang, L. E. Samelson, E. H. Lynch, R. T. Abraham, and P. J. Leibson. 1997. ZAP tyrosine kinase is required for the up-regulation of FAS ligand in activation-induced T cell apoptosis. J. Immunol. 159: 1135-1139
- Faris, M., N. Kokot, K. Latinis, S. Kasibhatla, O. R. Green, G. A. Koretzky, and A. Nel. 1998. The c-jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by upregulating Fas ligand expression. J. Immunol. 160: 134-144
- Friesen, C., J. Herr, P. H. Krammer, and K. M. Debatin. 1996. Involvement of the CD95 (APO-I/FAS) receptorl ligand system in drug-induced apoptosis in leukemia cells. Nature Med. 2: 574-578 https://doi.org/10.1038/nm0596-574
- Green, D. R., N. Droin, and M. Pinkoski. 2003. Activationinduced cell death in T cells. Immunol. Rev. 193: 70-81 https://doi.org/10.1034/j.1600-065X.2003.00051.x
- Hannun, Y. A. 1997. Apoptosis and dilemma of cancer chemotheraphy. Blood 89: 1845-1853
- Herr, I. and K. M. Debatin. 2001 Cellular stress response and apoptosis in cancertherapy. Blood 98: 2603-2614 https://doi.org/10.1182/blood.V98.9.2603
- Hyer, M. L., C. Voelkel-Johnson, S. Rubinchik, J. Dong, and J. S. Norris. 2000. Intracellular Fas ligand expression causes Fas-mediated apoptosis in human prostate cancer cells resistant to monoclonal antibody-induced apoptosis. Mol. Ther. 2: 348-358 https://doi.org/10.1006/mthe.2000.0139
-
Izquierdo, M., J. J. Leevers, C. J. Marshall, and D. Cantrell. 1993.
$p21^{ras}$ couples the T cell antigen receptor to extracellular signal-regulated kinase 2 in T lymphocytes. J. Exp. Med. 178: 1199-1208 https://doi.org/10.1084/jem.178.4.1199 - Park, H. W., D. Y. Jun, and Y. H. Kim. 2002. Apoptotic activity of insect pathogenic fungus Paecilomyces japonica toward human acute leukemia Jurkat T cells is associated with mitochondria-dependent caspase-3 activation regulated by bcl-2. J. Microbial. Biatechnal. 12: 950-956
- Jarvis, W. D., K. L. Auer, M. Spector, G Kunos, S. Grant, P. Hylemon, R. Mikkelsen, and P. Dent. 1997. Positive and negative regulation of JNKI by protein kinase C and p42 MAP kinase in adult rat hepatocytes. FEBS Lett. 412: 9-14 https://doi.org/10.1016/S0014-5793(97)00705-9
-
Kim, Y. H., M. J. Buchholz, and A. A. Nordin. 1993. Murine T-Iymphocyte proliferation induced by interleukin 2 correlates with a transient increase in
$p56^{lck}$ kinase activity and the tyrosine phosphorylation of a 97-kDa protein. Proc. Natl. Acad. Sci. USA 90: 3187-3191 - Krueger, A., S. C. Fas, S. Baumann, and P. H. Krammer. 2003. The role of CD95 in the regulation of peripheral T-cell apoptosis.lmmunol. Rev. 193: 58-69
- Lamy, T., J. H. Liu, T. H. Landowski, W. S. Dalton, and T. P. Loughran Jr. 1998. Dysregulation of CD95/CD95 ligandapoptotic pathway in CD3(+) large granular lymphocyte leukemia. Blood 92: 4771-4777
- Liu, B. and Z. Fan. 2001. The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway. Oncogene 20: 3726-3734 https://doi.org/10.1038/sj.onc.1204490
- Muller, M., S. Strand, H. Hug, E. M. Heinemann, H. Walczak, W. J. Hofmann, W. Stremmel, P. H. Krammer, and P. R. Galle. 1997. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-I/Fas) receptor/ligand system and involves activation of wild-type p53. J. Clin. Invest. 99: 403-413 https://doi.org/10.1172/JCI119174
- Nagarkatti, N. and B. A. Davis. 2003. Tamoxifen induces apoptosis in Fas+ tumor cells by upregulating the expression of Fas ligand. Cancer Chemother. Phamarcol. 51: 284-290
-
Oyaizu, N., S. Than, T. W. McCloskey, and S. Pahwa. 1995. Requirement of
$p56^{lck}$ in T-cell receptor/CD3 mediated apoptosis and Fas-ligand induction in Jurkat T cells. Biochem. Biophys. Res. Commun. 213: 994-1001 https://doi.org/10.1006/bbrc.1995.2227 - Pahlavani, M. A. 1998. T cell signaling: Effect of age. Front. Biosc. 3: 1120-1133 https://doi.org/10.2741/A349
- Ramoneda, B. M. and R. Perez-Tomas. 2002. Activation of protein kinase C for protection of celIs against apoptosis induced by the immunosuppressor prodigiosin. Biochem. Pharmacol. 63: 463-469 https://doi.org/10.1016/S0006-2952(01)00850-4
- Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K. J. TomaselIi, K. M. Debatin, P. H. Krammer, and M. E. Peter. 1998. Two CD95 (APO-l/Fas) signaling pathways. EMBO J. 17: 1675-1687 https://doi.org/10.1093/emboj/17.6.1675
- Shen, L., A. C. T. Liang, L. Lu, W. Y Au, Y. L. Kwong, R. H. S. Liang, and G. Srivastava. 2002. Frequent deletion of Fas gene sequence encoding death and transmembrane domains in nasal natural kilIer/T-celI lymphoma. Am. J. Pathol. 161: 2123-2131 https://doi.org/10.1016/S0002-9440(10)64490-2
- Shimizu, S., Y. Eguchi, H. Kosaka, W. Kamiike, H. Matsuda, and Y. Tsujimoto. 1995. Prevention of hypoxia-induced cell death by Bel-2 and Bel-xL. Nature 374: 811-813 https://doi.org/10.1038/374811a0
- Simonian, P. L., D. A. Grillot, and G. Nunez. 1997. BeI-2 and Bel-xL can differentially block chemotherapy-induced cell death. Blood 90: 1208-1216
- Stadheim, T. A. and G. L. Kusera. 1998. ExtracelIular signalregulated kinase (ERK) activity is required for TPAmediated inhibition of drug-induced apoptosis. Biochem. Biophys. Res. Commun. 245: 266-271 https://doi.org/10.1006/bbrc.1998.8410
- Thompson, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462 https://doi.org/10.1126/science.7878464
- Tsutsumi, A. T., M. Kubo, H. Fujii, J. Freire-Moar, C. W. Turck, and J. T. Ransom. 1993. Regulation of protein kinase C isoform proteins in phorbol ester-stimulated Jurkat T lymphoma celIs. J. Immunol. 150: 1746-1754
- Tudor, G, A. Aguilera, D. O. Halverson, N. D. Laing, and E. A. Sausville. 2000. Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bel-2 and Bel-xL protein levels. Cell Death Differ. 7: 574-586 https://doi.org/10.1038/sj.cdd.4400688
-
Veillette, A., L D. Horak, E. M. Horak, M. A. Bookman, and J. B. Bolen. 1988. Alterations of the lymphocyte-specific protein tyrosine kinase (
$p56^{lck}$ ) during T-ceII activation. Mol. Cell. Biol. 8: 4353-4361 https://doi.org/10.1128/MCB.8.10.4353 - VilIalba, M., S. Kasibhatla, L. Genestier, A. Mahboubi, D. R. Green, and A. Altman. 1999. Protein kinase C theta cooperates with calcineurin to induce Pas ligand expression during activation-induced T cell death. J. lmmunol. 163: 5813-5819
- Widmann, C., S. Gibson, M. B. Jarpe, and G. Johnson. 1999. Mitogen-activated protein kinase: Conservation of a threekinase module from yeast to human. Physiol. Rev. 79: 143-180 https://doi.org/10.1152/physrev.1999.79.1.143
- Wilson, D. J., K. A. Fortner, D. H. Lynch, R. R. Mattingly, J. G. Macara, J. A. Posada, and R. C. Budd. 1996. INK, but not MAPK, activation is associated with Fas-mediated apoptosis in human T cells. Eur. J. Immunol. 26: 989-994 https://doi.org/10.1002/eji.1830260505
- Zhu, L., X. Yu, Y. Akatsuka, J. A. Cooper, and C. Anasetti. 1999. Role of mitogen-activated protein kinases in activationinduced apoptosis of T cells. Immunology 97: 26-35 https://doi.org/10.1046/j.1365-2567.1999.00756.x
- Zhuang, S., M. C. Lynch, and I. E. Kochevar. 1998. Activation of protein kinase C is required for protection of celIs against apoptosis induced by singlet oxygen. FEBS Lett. 437: 158-162 https://doi.org/10.1016/S0014-5793(98)01222-8